BACKGROUND: The association between skeletal muscle mitochondrial function and CVD risk in healthy subjects is unknown. METHODS: Forty subjects were evaluated for CVD risk with lipid profile, oral glucose tolerance test and measurement of carotid intima-media thickness (cIMT). Skeletal muscle mitochondrial function was determined by phosphocreatine recovery after sub-maximal exercise with (31)Phosphorous-MRS and represented as τPCr. RESULTS: τPCr was positively associated with age (r=+0.41; P=0.009) and cIMT (r=+0.50; P=0.001) on univariate analyses. In multivariate regression analysis controlling for age, the association between τPCr and cIMT remained significant (β=0.003; P=0.03). This association remained significant after controlling for traditional risk factors for CVD including age, gender, tobacco use, BMI, blood pressure, cholesterol and fasting glucose in a combined model (β=0.003; P=0.04; R(2)=0.53; P=0.008 for overall model). CONCLUSIONS: These data suggest a novel association between skeletal muscle τPCr and increased cIMT, independent of age or traditional CVD risk factors.
BACKGROUND: The association between skeletal muscle mitochondrial function and CVD risk in healthy subjects is unknown. METHODS: Forty subjects were evaluated for CVD risk with lipid profile, oral glucose tolerance test and measurement of carotid intima-media thickness (cIMT). Skeletal muscle mitochondrial function was determined by phosphocreatine recovery after sub-maximal exercise with (31)Phosphorous-MRS and represented as τPCr. RESULTS: τPCr was positively associated with age (r=+0.41; P=0.009) and cIMT (r=+0.50; P=0.001) on univariate analyses. In multivariate regression analysis controlling for age, the association between τPCr and cIMT remained significant (β=0.003; P=0.03). This association remained significant after controlling for traditional risk factors for CVD including age, gender, tobacco use, BMI, blood pressure, cholesterol and fasting glucose in a combined model (β=0.003; P=0.04; R(2)=0.53; P=0.008 for overall model). CONCLUSIONS: These data suggest a novel association between skeletal muscle τPCr and increased cIMT, independent of age or traditional CVD risk factors.
Authors: Bovorn Sirikul; Barbara A Gower; Gary R Hunter; Dawnine E Larson-Meyer; Bradley R Newcomer Journal: Am J Physiol Endocrinol Metab Date: 2006-05-16 Impact factor: 4.310
Authors: Amy Fleischman; Stine Johnsen; David M Systrom; Mirko Hrovat; Christian T Farrar; Walter Frontera; Kathleen Fitch; Bijoy J Thomas; Martin Torriani; Hélène C F Côté; Steven K Grinspoon Journal: Am J Physiol Endocrinol Metab Date: 2007-02-06 Impact factor: 4.310
Authors: Douglas E Befroy; Kitt Falk Petersen; Sylvie Dufour; Graeme F Mason; Robin A de Graaf; Douglas L Rothman; Gerald I Shulman Journal: Diabetes Date: 2007-02-07 Impact factor: 9.461
Authors: Delyth Graham; Ngan N Huynh; Carlene A Hamilton; Elisabeth Beattie; Robin A J Smith; Helena M Cochemé; Michael P Murphy; Anna F Dominiczak Journal: Hypertension Date: 2009-07-06 Impact factor: 10.190